Overexpression of PART1, SNHG11, LINC00173 and MIR17HG is widely involved in tumorigenesis and malignant progression of several types of cancer, such as glioma, breast cancer, lung cancer and colorectal cancer [48–52]. The gene discussed is MIR17HG; the disease is breast carcinoma.